On July 4, the United States enacted the One Big Beautiful Bill Act, a sweeping tax-and-spending package containing some 35 provisions affecting the energy sector. Here, we highlight the most significant measures and examine how the legislation could reshape energy-investment decisions for both corporations and investors.Host: Mike Disabato, MSCI ESG ResearchGuest: Chris Cote, MSCI ESG Research
--------
22:51
--------
22:51
Making Food Healthier
Junk food is at the center of the political conversation in America and globally, with discussions about ultra-processed and artificial foods, and the changes we need to make to food, and how hungry we are but none of the food is "good." It is a thing! But what does it mean for food companies? And what does it mean for our social pillar where we look at opportunities in nutrition and health - which assess which companies are likely to meet market demand for products with improved nutritional or health profiles. Listen to find out!Host: Mike Disabato, MSCI ESG ResearchGuest: Cole Martin, MSCI ESG Research
--------
15:47
--------
15:47
From Targets to Tactics: How We’re Scoring the Energy Transition
The energy transition isn’t a straight line. Investors are increasingly look to understand where and how emissions create portfolio risk. In this episode, we explore MSCI’s new energy transition framework and take a closer look at materiality-weighted emissions, a new metric that draws a bolder line to company performance. Host: Bentley Kaplan, MSCI ESG ResearchGuests: Chris Cote & Guido Giese, MSCI ESG Research
--------
20:22
--------
20:22
An Update on the Carbon Credit Markets
How is it going with the carbon credit markets? Are they pricing credits accurately? Is the vitally important Carbon Offsetting and Reduction Scheme for International Aviation also known as CORSIA that relies on functioning carbon credit markets working out? Listen to this episode of Sustainability Now to find out!Host: Mike Disabato, MSCI ESG ResearchGuest: Utkarsh Akhouri and Nicholas Baldwin, MSCI Carbon Markets
--------
16:37
--------
16:37
A Breakthrough in the Fight Against Superbugs
Could Swiss pharmaceutical company Roche’s late-stage antibiotic trials signal new hope against antibiotic‐resistant pathogens? On this special REPLAY episode (originally aired August 2024), we take a deep dive into the state of antimicrobial resistance, from hospital wards to farm fields. As these microscopic threats drive up healthcare costs, jeopardize food security, and reshape insurance risk worldwide, understanding the crisis has never been more critical. But while the need to act is clear, the solutions remain complex. In this episode, we examine whether there’s a compelling investment case for fighting back, and what that could mean for the future of global health.Host: Bentley KaplanGuest: Namita Nair
News and investment research brought to you weekly covering major market trends and new research insights. With topics ranging from climate impact on investment portfolios, corporate actions, trending investment topics, and emerging sustainability issues, hosts Mike Disabato and Bentley Kaplan of MSCI ESG Research walk through the latest news and research that is top of mind for the week.
New Zealand